My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

Similar documents
Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Medical Therapy for Pediatric IBD: Efficacy and Safety

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Understanding Inflammatory Bowel Diseases (IBD):

Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego

Crohn s Disease. Resident Lecture 1/17/19

Slide 1 Medications in inflammatory bowel disease a primer for health care providers. Slide 2. Slide 3 Theory of pathogenesis. IBD - epidemiology

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Update in Pediatric IBD: 2018

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

Treatment Options. Suresh Pola, MD Kaiser San Diego

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

Dietary Options for Inflammatory Bowel Disease

Treating Crohn s and Colitis in the ASC

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

Ali Keshavarzian MD Rush University Medical Center

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online Support Group.

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

The Road to Remission

Medical therapies and IBD

Speaker Introduction

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants

10/23/2014. Program Goals

CCFA. Crohns Disease vs UC: What is the best treatment for me? November

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Selby Inflamm Bowel Dis. 2008:14:

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

What is Crohn's disease?

What is ulcerative colitis?

WHAT IS ULCERATIVE COLITIS?

What Will This Talk Cover? 101: The Basics of Inflammatory Bowel Disease. Terms & Abbreviations. What Is Normal GI Anatomy?

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda

COPYRIGHT. Inflammatory Bowel Disease What Every Clinician Needs to Know. Adam S. Cheifetz, MD. Director, Center for Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Michael D. Kreines, M.D.

INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease

Inflammatory Bowel Disease Medical Exam Questionnaire

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)

Improving outcome of Inflammatory Bowel Disease in children

What is Inflammatory Bowel Disease (IBD)?

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012

Is there an anti-inflammatory diet in IBD?

The ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012

This program is supported by an educational grant from Janssen Biotech Inc, and a sponsorship from Takeda.

Pharmacotherapy of Inflammatory Bowel Disorder

Inflammatory Bowel Disease

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

There is no single IBD diet

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10

How to manage your IBD patient: Tips for diagnosis and care

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board

INFLAMMATORY BOWEL DISEASE

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE

ENTYVIO (VEDOLIZUMAB)

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

Pharmacotherapy of Inflammatory Bowel Disorder

The role of Surgery and Stomas in IBD

IBD Module 2: Medication and Patient Management. Kami Roake, PharmD Rheumatology & Gastroenterology Pharmacist University of Utah Hospitals & Clinics

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13

P a g e 1. Inflammatory Bowel Disease Guidelines

Personalized Medicine in IBD

Doncaster & Bassetlaw Medicines Formulary

Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it?

IBD Updates. Themes in IBD IBD management journey. New tools for therapeutic monitoring. First-line treatment in IBD

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

Carefirst.+.V Family of health care plans

Managing. Inflammatory Bowel Disease. Slide 1. Slide 2. Slide 3. Disclosures. Vijay Yajnik, MD., PhD 01/25/14. None relevant to this talk

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

Biologic Therapy for Inflammatory. Is Top-Down Too Top-Heavy? S. Devi Rampertab, MD, FACG, AGAF Associate Professor of Medicine University of Florida

Surgical Therapies for the Treatment of IBD!

September 12, 2015 Millie D. Long MD, MPH, FACG

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Understanding Inflammatory Bowel Diseases: What Every Patient Needs to Know

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Hot Topics In Nutrition & IBD January 6, Kate Vance, RD Wael N. Sayej, MD

We will discuss: Inflammatory Bowel Diseases. Life With IBD. What Are the Potential Causes of IBD?

Which is the Safest Strategy to Treat Moderate to Severe IBD?

Transcription:

My Child Has Inflammatory Bowel Disease : Why? What now? What s next? George M. Zacur, M.D., M.S. Clinical Assistant Professor Department of Pediatrics and Communicable Diseases Division of Gastroenterology University of Michigan C.S. Mott Children s Hospital

Disclosures No disclosure Thank you Crohn's & Colitis Foundation

Objectives What is Inflammatory Bowel Disease (IBD)? Crohn Disease or Ulcerative Colitis? WHY? I don t have IBD. How did my child get it? The perfect storm of IBD Genetics and the environment WHAT NOW? How do we treat it? (Currently) Are these medications safe? What about surgery? Diet, probiotics, and fecal transplant. WHAT S NEXT? What should we expect? Disease course Future directions Transition of care

What is IBD? IBD is comprised of two distinct entities: Ulcerative Colitis (UC) and Crohn Disease (CD). About 15% with IBD have only colonic involvement, but cannot be distinguished between CD and UC, and this is termed Indeterminate Colitis (IC). IBD Ulcerative colitis Crohn Disease Indeterminate Colitis

What is IBD? Ulcerative Colitis (UC): Relapsing episodes of superficial mucosal inflammation, almost always affecting the rectum, in a continuous fashion Crohn Disease (CD): Characterized by transmural inflammation rather than superficial, skip lesions, fibrosis/strictures, fistulas, microperforations, and abscesses

What is IBD? Crohn Disease: Any part of the GI tract Can skip areas Rectal sparing Non-caseating granulomas Transmural inflammation Fistulas and abscesses Strictures (scar) common Ileum commonly involved Perianal disease 20% colon-only involved Ulcerative Colitis: Colon only Continuous No rectal sparing No granulomas Mucosal inflammation Can have inflammation in the stomach and duodenum Can have relative rectal sparing, cecal patch, or back-wash ileitis

What is IBD? Signs/Symptoms Crohn Disease Ulcerative Colitis Rectal Bleeding ++ ++++ Abdominal Pain ++++ +++ Diarrhea ++ ++++ Weight loss ++++ ++ Growth Failure +++ + Perianal Disease ++ Mouth Ulcers ++ + Erythema Nodosum + + Fevers ++ + Anemia +++ +++ Arthritis + + Adapted from CHDNF/NASPGHAN 2007

Geographic Distribution Cosnes, IBD 2011

IBD in the USA >1 million Americans have IBD (>1.5 million?) Incidence in the pediatric age group has doubled over the past decade Current estimates report more than 50,000 children have IBD (some report more than 80,000) 20-30 % of adults with IBD developed symptoms or were diagnosed as children Rare before age 5 yrs, but reported as young as infancy Very Early Onset (VEO)-IBD

Percent of Cases Age of Onset 25 Years 0 10 20 30 40 50 60 70 80 20 15 10 5 0 Loftus, Gastro 2003; 124:abstract 278

Gastro 2006 Age of Onset

WHY? I don t have IBD How did my child get it? The perfect storm of IBD Genetics and the environment

How did my child get IBD? The perfect storm of IBD Genetics ( 200 IBD genes) Immune System (Mucosal) IBD Gut Environment (Microbiome)

How did my child get IBD? The new perfect storm of IBD Genetics Immune System IBD Gut Flora Environmental Triggers

Genetics The most important risk factor for IBD is a positive family history (15-30%) Genetic influence is greater in CD than UC Genetically complex Genetic defects Mucosal barrier function Mucosal immune system 200 genes isolated more than half are common to both diseases Schreiber, Semin Immunology 2009 Williams, Inflamm Bowel Dis 2002 Orholm, Scand J Gastroenterol 2000

Gut Microbiome (Gut Bacteria) Frank, PNAS 2007

How did my child get IBD? Different theories: Hygiene theory? Early antibiotics? Vaginal birth vs C-Section? Breast feeding vs formula feeding? Environmental triggers?

Environmental Triggers Smoking: CD Oral contraceptives: CD & UC NSAIDs: CD & UC Vitamin D deficiency: CD Perinatal & childhood infections/microbial exposures? Stress? Food or food additives?

Theories of Triggers Genetics Triggers affecting the microbiome: Delivery method, Early diet Triggers that start inflammation: Infections, Antibiotics, NSAID s, Smoking Diet and lack of nutrients can influence inflammation IBD

WHAT NOW? How do we treat it? (Currently) Are these medications safe? What about surgery? Diet, probiotics, and fecal transplant.

How do we treat it? Principles of Medical Management Enhance quality of life while avoiding long-term toxicity Induction of Remission start the healing process Pitfall is premature withdrawal of inductive therapy: failure to complete induction virtually guarantees failure of maintenance Maintenance of Remission keep healing going Clinically resolution of symptoms (bleeding, urgency, passage of mucous and diarrhea) Endoscopically gut lining without ulcers/exudate/friability/ granularity Clinical remission precedes endoscopic remission which in turn precedes histologic remission and vice versa for flare

Therapy (old way) Disease Severity Resection/Diversion Colectomy Severe Moderate Surgery Biologics Methotrexate Azathioprine/6-MP Prednisone Anti-TNF s: Infliximab, Adalimumab, Certolizumab Ustekinumab Vedolizumab Mild CD Enteral Nutrition Budesonide Antibiotics Aminosalicylates UC

Therapy Disease Severity Severe Moderate Surgery Methotrexate Azathioprine/6-MP Prednisone Biologics Anti-TNF s: Infliximab, Adalimumab, Certolizumab Ustekinumab Vedolizumab Mild CD Enteral Nutrition Budesonide Antibiotics Aminosalicylates UC

Are Aminosalycilates safe? Aminosalycilates: Mesalamine, Sulfasalazine, Balsalazide Effective induction and maintenance of mild to moderate UC; effective maintenance for moderate UC after induction with steroids; do not work for Crohn Disease Tolerated well Headaches; Worse diarrhea/rectal bleeding Kidney disease (very rare) Oral and rectal combination better than oral alone, especially for distal UC (end of the colon)

Are Immunomodulators safe? Azathioprine (Imuran)/Mercaptopurine (6-MP) Effective for maintenance of CD and UC (earlier is better); need a bridging medication Pancreatitis, Rash, Flu-like symptoms, GI intolerance Lower white blood cell count Liver damage (temporary) rare Skin Cancer rare Lymphoma extremely rare (4 per 10,000) Methotrexate Used as monotherapy or combination with anti-tnf s better for CD Nausea Liver and lung damage (temporary and rare) Birth defects Risk of cancer is small to negligible (need more data)

Are Biologics safe? Anti-TNF s: Infliximab (Remicade), Adalimumab (Humira), Certolizumab (Cimzia), Golimumab (Simponi) Effective for induction and maintenance of remission in CD and UC Highly effective for fistula therapy in CD (best!) Rash, fever, headache Low risk of serious infections, except for TB, Varicella, and Influenza Antibodies and/or loss of response Little evidence for increase risk of cancer with Anti-TNF alone

Are Biologics safe? Ustekinumab (Stelara) Initially used for psoriasis found to be effective for CD Slightly better side effect profile than the anti-tnf s Effective for CD only One infusion, then every 8 week injection Still need more data fistulae, strictures, recurrence post-op Vedolizumab (Entyvio) Both take months to work. Significantly better side effect profile Effective for both UC and CD (UC>CD) Infusion schedule similar to other biologics Still need more data fistula, stricture

Are Steroids safe? Corticosteroids: Prednisone, Prednisolone, Methylprednisolone, Hydrocortisone Extremely effective anti-inflammatory Not to be used alone, but rather as a bridge NOT MAINTENANCE DRUGS! Short and long-term side effects: Skin problems, stretch marks Infections! Growth failure! Bone disease osteoporosis, degenerative joint disease Hypertension, Diabetes, Cataracts, Glaucoma Gastritis, ulcers

What about surgery? Surgery is not necessarily a failure of medication >70% of CD patients will undergo one surgery;? 1/3 UC Colectomy (colon removal) UC more than CD Severe UC, refractory to steroids/medications, severe Crohn colitis Pouchitis, cuffitis, diarrhea Diversion (Temporizing Ileostomy) CD more than UC Severe perianal CD, severe Crohn colitis, severe UC Diarrhea, dehydration Small bowel resection Ileocecal resection Most common surgery of CD Resume/reinitiate therapy Recurrence (Crohn Disease returns where ends are connected)

Do we have to use medications? Risks of poor outcomes from the diseases themselves are higher than the side effects of medical or surgical therapy Crohn Disease: Growth failure, short stature, poor nutrition Fistula, abscess, infection Stricture, small bowel obstruction Colon cancer Death Ulcerative Colitis: Profuse diarrhea, severe rectal bleeding, anemia, transfusions Growth failure, infection Toxic megacolon, perforation Colon cancer Death

Diet Theory: A regular diet contains harmful components and can alter the gut microbiome which can lead to inflammation. High dietary intakes of total fats, polyunsaturated fatty acids, omega-6 and meat were associated with an increased risk of CD and UC High fiber and fruit intakes were associated with decreased CD risk (but not UC) High vegetable intake was associated with decreased UC risk. Hou, Am J Gastroenterol 2011 Ananthakrishnan, Gastro 2013

Enteral Nutrition Elemental (formula) diet: 80-100% for 6-8 weeks for induction of remission of CD Study that compares partial vs exclusive enteral nutrition: GREAT! Greater mucosal healing with a more formula diet Decreased fecal calprotectin THEN WHAT? PLEASE study, AIBD, Orlando 2014 Study looking at partial enteral nutrition with a CD exclusion diet: Improvement in labs and disease severity scoring High remission rate Sigall-Boneh, IBD 2014

Specialized Diets Gluten-free Low FODMAPS No/Low dairy Low roughage Paleo Diet There is no evidence that these diets improve inflammation or prevent disease complications, although they may improve symptoms for some patients.

Probiotics Probiotics: "live microorganisms, which when consumed in adequate amounts, confer a health effect on the host No good evidence that they improve CD or UC Some good evidence they are effective in prevention of pouchitis after colectomy with pouch formation May help symptoms, but not the disease (can t hurt unless there is hardware) Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, October 2001

Fecal Transplant Fecal Microbiota Transplant (FMT): stool is collected from a tested donor, mixed with saline or other solution, strained, and placed in a patient, by endoscopy, enteral tube (NG or NJ), or enema. May work in some specific cases (C. diff) No good evidence for use in IBD need more studies Harmful if not done correctly (Do not try this at home!)

WHAT S NEXT? What should we expect? Disease course Future directions Transition of care

What should we expect? 1 st year may be rough Many medications initially Labs Good and bad days Flares Scopes Imaging, MRI Surgery GOAL: NORMAL LIFE!

Future Directions Goal of therapy: Optimizing efficacy while minimizing toxicity fancy way of saying finding the right medication, with minimal side effects, and best at treating the disease Individualized therapy based on multiple factors such as disease location, genetics, molecular makeup Altering the diet to modify the gut microbiome as a potential for disease prevention and/or therapy Maybe immunization against bacteria causing IBD?

Research

Transition of care Know: Your disease Your medications what, why, how much, side effects, interactions Your test results and what they mean Develop Independence and Assertiveness: Take responsibility for knowing medications and adherence Make your own appointments with your doctor tell your history, don t rely on your parents Plan for the future how will you manage your disease at school? Work? Health Insurance? Transition not Transfer: Make introductions dialogue between docs, not just records

Transition: goals and milestones

Prior to transitioning Patients: Speak up! Take ownership of your health and your treatment. Parents: Allow child to lead the appointment.

When transitioning Do your research Have pediatric doctor speak with new doctor Prepare yourself before appointments GET TO KNOW Familiarize yourself with insurance information Read all medical documents YOUR SOCIAL WORKER!

THANK YOU!